Open AccessGlobal Respiratory Syncytial Virus–Related Infant Community Deaths
Author(s) -
Natalie I Mazur,
Yvette N Löwensteyn,
Joukje Willemsen,
Christopher Gill,
Leah S Forman,
Lawrence Mwananyanda,
Dianna M. Blau,
Robert F. Breiman,
Shabir A. Madhi,
Sana Mahtab,
Emily S. Gurley,
Shams El Arifeen,
Nega Assefa,
J. Anthony G. Scott,
Dickens Onyango,
Beth A Tippet Barr,
Karen L. Kotloff,
Samba O. Sow,
Inácio Mandomando,
Ikechukwu U. Ogbuanu,
Amara Jambai,
Quique Bassat,
Mauricio T. Caballero,
Fernando P. Polack,
Saad B. Omer,
Abdul Momin Kazi,
Eric A. F. Simões,
Ashish Satav,
Louis Bont
Publication year - 2021
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciab528
Subject(s) - medicine , pediatrics , cause of death , vaccination , immunology , disease
Respiratory syncytial virus (RSV) is a leading cause of pediatric death, with >99% of mortality occurring in low- and lower middle-income countries. At least half of RSV-related deaths are estimated to occur in the community, but clinical characteristics of this group of children remain poorly characterized.